Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.77 |
| ▸ | PPARG | P37231 | 7/20 | 0.77 |
| ▸ | PPARD | Q03181 | 7/20 | 0.77 |
| ▸ | PPARA | Q07869 | 7/20 | 0.77 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.77 |
| ▸ | TSHR | P16473 | 4/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.77 |
| ▸ | FABP4 | P15090 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | TLR2 | O60603 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.77 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.77 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | ESR1 | P03372 | 1/20 | 0.77 |
| ▸ | PDE4A | P27815 | 1/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL17101371 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL109144 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetrabuthylammonium SCHEMBL8778048 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetrabuthylammonium SCHEMBL1716194 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetrabuthylammonium SCHEMBL2230012 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetrabuthylammonium SCHEMBL28280586 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetrabuthylammonium SCHEMBL2230705 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL5152853 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5535683 | 0.98 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5533401 | 0.98 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116672460-A | Polyvanadate-based compound capable of resisting obesity and reducing obesity-related inflammation, and preparation and application thereof | 华南理工大学 | 2023-09-01 | — | — | CN | claimed |
| CN-116672460-A | Polyvanadate-based compound capable of resisting obesity and reducing obesity-related inflammation, and preparation and application thereof | 华南理工大学 | 2023-09-01 | — | — | CN | disclosed |
| CN-110352229-A | Semiconductor nano material | 默克专利股份有限公司 | 2019-10-18 | — | — | CN | disclosed |
| WO-2018146120-A1 | SEMICONDUCTOR NANOSIZED MATERIAL | MERCK PATENT GMBH (DE) | 2018-08-16 | — | — | WO | disclosed |
| US-20170096614-A1 | HALOGEN FREE IONIC LIQUIDS AS LUBRICANT OR LUBRICANT ADDITIVES AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-04-06 | — | — | US | disclosed |
| US-8426625-B2 | Bis-platinum complexes with antitumor activity | CELL THERAPEUTICS, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20100292322-A1 | Bis-Platinum Complexes With Antitumor Activity | CELL THERAPEUTICS, INC. | 2010-11-18 | — | — | US | disclosed |
| EP-1968991-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | Sede Secondaria Della Cell Therapeutics, Inc. (IT) | 2008-09-17 | — | — | EP | disclosed |
| EP-1862329-A1 | Ink jet recording material and method of producing ink jet recording material | OJI PAPER CO., LTD. (JP) | 2007-12-05 | — | — | EP | disclosed |
| WO-2007071415-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | CELL THERAPEUTICS, INC. - SEDE SECONDARIA (IT) | 2007-06-28 | — | — | WO | disclosed |
| CN-1891764-A | Composite fine particles, dispersion, method of producing dispersion, ink jet recording material, and method of producing ink jet recording material | OJI PAPER CO (JP) | 2007-01-10 | — | — | CN | disclosed |
| US-20070003716-A1 | Composite fine particles, dispersion, method of producing dispersion, ink jet recording material, and method of producing ink jet recording material | OJI PAPER CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| EP-1739136-A1 | Composite fine particles and ink jet recording material containing these particles. | OJI PAPER CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292322-A1 | Bis-Platinum Complexes With Antitumor Activity | IDH3B, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IDH1 | GPR84 4253/4885PPARG 1538/4885PPARD 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.